Institution statistics

GENIBET - BIOPHARMACEUTICALS SA - Portugal 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 8
As coordinator: 0
As participant: 8
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 1.879.216 11.875 1
2019 0 8.391.240 861.250 1
2017 0 10.599.993 108.993 1
2015 0 5.825.580 705.250 1
2013 0 5.986.903 1.541.187 1
2012 0 6.549.575 601.945 2
2008 0 2.984.999 271.364 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA7
COMMISSARIAT A L'ENERGIE ATOMIQUE3
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG3
AFFILOGIC SAS2
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
EATRIS ERIC2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN VACCINE INITIATIVE EWIV2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA2
INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONNEMENT2
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER2
MINISTERIE VAN VOLKSGEZONDHEID WELZIJN EN SPORT2
SCLAVO VACCINES ASSOCIATION2
STATENS SERUM INSTITUT2
STICHTING BIOMEDICAL PRIMATE RESEARCH CENTER2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITA DEGLI STUDI DI SIENA2
UNIVERSITAT AUTONOMA DE BARCELONA2
WAGENINGEN UNIVERSITY2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
AQUAPORIN AS1
ASA SPEZIALENZYME1
ATRC AURIGON TOXICOLOGIAI KUTATOKOZPONT KORLATOLT FELELOSSEGU TARSASAG1
AZIENDA SPECIALE INNOVHUB STAZIONI SPERIMENTALI PER L'INDUSTRIA1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
CANCER RESEARCH UK1
CEINGE BIOTECNOLOGIE AVANZATE SCARL1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DEPARTMENT OF HEALTH1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ELAN PHARMA INTERNATIONAL LIMITED1
EUROPEAN CROHN S AND COLITIS ORGANISATION1
FERRING PHARMACEUTICALS AS1
FIRALIS SAS1
FLANDERS VACCINE1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
GLAXOSMITHKLINE VACCINES1
HOSPICES CANTONAUX CHUV1
INSERM TRANSFERT1
INSTITUTO DE SALUD CARLOS III1
INSTRUCT ACADEMIC SERVICES LIMITED1
INSTRUCTERIC1
INTESTINAL BIOTECH DEVELOPMENT1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LUNDS UNIVERSITET1
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY1
MERCK KGAA1
MOLECULES OF MAN AB1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF NOTTINGHAM1
UNIVERSIDAD DE BUENOS AIRES1
UNIVERSIDADE NOVA DE LISBOA1
UNIVERSITAET LEIPZIG1
UNIVERSITE DE GENEVE1
UNIVERSITE DE LAUSANNE1
UNIVERSITE LIBRE DE BRUXELLES1
UNIVERSITE LOUIS PASTEUR STRASBOURG 11
UNIVERSITEIT ANTWERPEN1
UNIVERSITEIT GENT1
UNIVERSITEIT LEIDEN1
UNIVERSITY OF GLASGOW1
VACCINE FORMULATION INSTITUTE LIMITED1
VACCINE FORMULATION INSTITUTELTD1
VAKZINE PROJEKT MANAGEMENT1
Constancy:

Total number of partners:100

Partner loyalty:
Frequent Partner: (> 2 projects): 13
Rare Partner: 87

Frequent / Rare Partner Ratio: 0.15

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES2
INDUSTRY AND TECHNOLOGY1
RTD HORIZONTAL TOPICS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-06-01DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE TRANSVAC-DSparticipant1.879.21625
2019-06-01Vaccine for prevention and treatment of Trypanosoma cruzi infection CRUZIVAXparticipant8.391.24011
2017-05-01European Vaccine Research and Development Infrastructure TRANSVAC2participant10.599.99326
2015-03-01Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes DiViNeparticipant5.825.5806
2013-01-01Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial HEPAMABparticipant5.986.9037
2012-11-01"From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV" BRAINVECTORSparticipant1.597.78312
2012-01-01Scaffolds for alternative delivery SADELparticipant4.951.79210
2008-10-01Nonhuman adenovirus vectors for gene transfer to the brain BRAINCAVparticipant2.984.99911

Alias institution names:
  • GENIBET BIOPHARMACEUTICALS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum